Research Article
No access
Published Online: 29 January 2013

Contact Heat-Evoked Potential Stimulation for the Evaluation of Small Nerve Fiber Function

Publication: Diabetes Technology & Therapeutics
Volume 15, Issue Number 2

Abstract

Background: Small fiber peripheral neuropathy (SFN) is emerging as a common complication in diabetes. Currently there are few, not easily available methods of determining the integrity of small nerve fibers. This study was designed to determine the utility of a noninvasive technique, contact heat-evoked potential stimulation (CHEPS), on the identification of SFN and compare it with standardized measures of diabetic peripheral neuropathy (DPN).
Subjects and Methods: We evaluated 31 healthy controls and 30 participants with type 2 diabetes and DPN using neurologic examination, nerve conduction studies (NCS), autonomic function tests, quantitative sensory tests (QSTs), and CHEPS. Contact heat was administered to the thenar eminence, volar and dorsal forearms, lower back, and distal lower limb. Evoked potentials were recorded from the skull vertex. Latencies and amplitudes were determined.
Results: Intrapeak amplitude (IA) values were significantly reduced in the DPN group at the lower back (44.93±6.5 vs. 23.87±3.36 μV; P<0.01), lower leg (15.87±1.99 vs. 11.68±1.21 μV; P<0.05), and dorsal forearm (29.89±8.86 vs. 14.96±1.61 μV; P<0.05). Pooled data from both groups showed that IA values at different sites significantly correlated with clinical neurologic scores, NCS, QSTs, and autonomic function. Receiver operator characteristic curve analysis, used to evaluate the performance of CHEPS in detecting nerve dysfunction, was most significant for IA at the lower back (area under the curve, 0.778;±SE, 0.06; 95% confidence interval, 0.654–0.875; P<0.0001).
Conclusions: This study suggests that CHEPS is a novel, noninvasive technique able to detect impairment of small nerve fiber function from skin to cerebral cortex, providing an objective measure of C and Aδ nerve dysfunction.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Vinik AUllal JParson HKCasellini CM. Diabetic neuropathies: clinical manifestations and current treatment optionsNat Clin Pract Endocrinol Metab20062269-281. 1. Vinik A, Ullal J, Parson HK, Casellini CM: Diabetic neuropathies: clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab 2006;2:269–281.
2.
Vinik EJHayes RPOglesby ABastyr EBarlow PFord-Molvik SLVinik AI. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathyDiabetes Technol Ther20057497-508. 2. Vinik EJ, Hayes RP, Oglesby A, Bastyr E, Barlow P, Ford-Molvik SL, Vinik AI: The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther 2005;7:497–508.
3.
Vinik AIPark TSStansberry KBPittenger GL. Diabetic neuropathiesDiabetologia200043957-973. 3. Vinik AI, Park TS, Stansberry KB, Pittenger GL: Diabetic neuropathies. Diabetologia 2000;43:957–973.
4.
Vinik AErbas TStansberry KBPittenger G. Small fiber neuropathy and neurovascular disturbances in diabetes mellitusExp Clin Endocrinol Diabetes2001109Suppl 2S451-S473. 4. Vinik A, Erbas T, Stansberry KB, Pittenger G: Small fiber neuropathy and neurovascular disturbances in diabetes mellitus. Exp Clin Endocrinol Diabetes 2001;109(Suppl 2):S451–S473.
5.
Al-Shekhlee AChelimsky TCPreston DC. Review: small-fiber neuropathyNeurologist20028237-253. 5. Al-Shekhlee A, Chelimsky TC, Preston DC: Review: small-fiber neuropathy. Neurologist 2002;8:237–253.
6.
Vinik A. The approach to the management of the patient with neuropathic painJ Clin Endocrinol Metab2010954802-4811. 6. Vinik A: The approach to the management of the patient with neuropathic pain. J Clin Endocrinol Metab 2010;95:4802–4811.
7.
Pittenger GLRay MBurcus NIMcNulty PBasta BVinik AI. Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patientsDiabetes Care2004271974-1979. 7. Pittenger GL, Ray M, Burcus NI, McNulty P, Basta B, Vinik AI: Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care 2004;27:1974–1979.
8.
Boyd ALBarlow PPittenger GSimmons KVinik A. Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with Type 2 diabetes mellitusDiabetes Metab Syndr Obes20103431-437. 8. Boyd AL, Barlow P, Pittenger G, Simmons K, Vinik A: Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with Type 2 diabetes mellitus. Diabetes Metab Syndr Obes 2010;3:431–437.
9.
Smith AGRamachandran PTripp SSingleton JR. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathyNeurology2001571701-1704. 9. Smith AG, Ramachandran P, Tripp S, Singleton JR: Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 2001;57:1701–1704.
10.
Lauria GHsieh SJohansson OKennedy WLeger JMellgren SNolano MMerkies ISPolydefkis MSmith AGSommer CValls-Solé J. European Federation of Neurological Societies/Peripheral Nerve Society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve SocietyEur J Neurol201017903-912. 10. Lauria G, Hsieh S, Johansson O, Kennedy W, Leger J, Mellgren S, Nolano M, Merkies IS, Polydefkis M, Smith AG, Sommer C, Valls-Solé J: European Federation of Neurological Societies/Peripheral Nerve Society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010;17:903–912.
11.
Tavakoli MQuattrini CAbbott CKallinikos PMarshall AFinnigan JMorgan PEfron NBoulton AJMalik RA. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathyDiabetes Care2010331792-1797. 11. Tavakoli M, Quattrini C, Abbott C, Kallinikos P, Marshall A, Finnigan J, Morgan P, Efron N, Boulton AJ, Malik RA: Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 2010;33:1792–1797.
12.
Stansberry KBPeppard HRBabyak LMPopp GMcNitt PMVinik AI. Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunctionDiabetes Care1999221549-1554. 12. Stansberry KB, Peppard HR, Babyak LM, Popp G, McNitt PM, Vinik AI: Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction. Diabetes Care 1999;22:1549–1554.
13.
Stansberry KBScanelli JAMcNitt PMVinik AI. Nitric oxide production mediates neurogenic vasodilation in human skin but is not impaired in type 2 diabetesDiabetes200049Suppl 1A33. 13. Stansberry KB, Scanelli JA, McNitt PM, Vinik AI: Nitric oxide production mediates neurogenic vasodilation in human skin but is not impaired in type 2 diabetes. Diabetes 2000;49(Suppl 1):A33.
14.
Agostino RCruccu GRomaniello AInnocenti PInghilleri MManfredi M. Dysfunction of small myelinated afferents in diabetic polyneuropathy, as assessed by laser evoked potentialsClin Neurophysiol2000111270-276. 14. Agostino R, Cruccu G, Romaniello A, Innocenti P, Inghilleri M, Manfredi M: Dysfunction of small myelinated afferents in diabetic polyneuropathy, as assessed by laser evoked potentials. Clin Neurophysiol 2000;111:270–276.
15.
Valeriani MLe Pera DNiddam DChen ACArendt-Nielsen L. Dipolar modelling of the scalp evoked potentials to painful contact heat stimulation of the human skinNeurosci Lett200231844-48. 15. Valeriani M, Le Pera D, Niddam D, Chen AC, Arendt-Nielsen L: Dipolar modelling of the scalp evoked potentials to painful contact heat stimulation of the human skin. Neurosci Lett 2002;318:44–48.
16.
Granovsky YGranot MRony-Rueven NYarnitsky D. Objective correlate of subjective pain perception by contact heat-evoked potentialsJ Pain2008953-63. 16. Granovsky Y, Granot M, Rony-Rueven N, Yarnitsky D: Objective correlate of subjective pain perception by contact heat-evoked potentials. J Pain 2008;9:53–63.
17.
Chen ACNiddam DMArendt-Nielsen L. Contact heat evoked potentials as a valid means to study nociceptive pathways in human subjectsNeurosci Lett200131679-82. 17. Chen AC, Niddam DM, Arendt-Nielsen L: Contact heat evoked potentials as a valid means to study nociceptive pathways in human subjects. Neurosci Lett 2001;316:79–82.
18.
Itskovich VVFei DYHarkins SW. Psychophysiological and psychophysical responses to experimental pain induced by two types of cutaneous thermal stimuliInt J Neurosci200010563-75. 18. Itskovich VV, Fei DY, Harkins SW: Psychophysiological and psychophysical responses to experimental pain induced by two types of cutaneous thermal stimuli. Int J Neurosci 2000;105:63–75.
19.
Harkins SWPrice DDRoy AItskovich VVFei DY. Somatosensory evoked potentials associated with thermal activation of type II Adelta mechanoheat nociceptive afferentsInt J Neurosci200010493-111. 19. Harkins SW, Price DD, Roy A, Itskovich VV, Fei DY: Somatosensory evoked potentials associated with thermal activation of type II Adelta mechanoheat nociceptive afferents. Int J Neurosci 2000;104:93–111.
20.
Granovsky YMatre DSokolik ALorenz JCasey KL. Thermoreceptive innervation of human glabrous and hairy skin: a contact heat evoked potential analysisPain2005115238-247. 20. Granovsky Y, Matre D, Sokolik A, Lorenz J, Casey KL: Thermoreceptive innervation of human glabrous and hairy skin: a contact heat evoked potential analysis. Pain 2005;115:238–247.
21.
Chao CCHsieh STChiu MJTseng MTChang YC. Effects of aging on contact heat-evoked potentials: the physiological assessment of thermal perceptionMuscle Nerve20073630-38. 21. Chao CC, Hsieh ST, Chiu MJ, Tseng MT, Chang YC: Effects of aging on contact heat-evoked potentials: the physiological assessment of thermal perception. Muscle Nerve 2007;36:30–38.
22.
Chao CCHsieh SCTseng MTChang YCHsieh ST. Patterns of contact heat evoked potentials (CHEP) in neuropathy with skin denervation: correlation of CHEP amplitude with intraepidermal nerve fiber densityClin Neurophysiol2008119653-661. 22. Chao CC, Hsieh SC, Tseng MT, Chang YC, Hsieh ST: Patterns of contact heat evoked potentials (CHEP) in neuropathy with skin denervation: correlation of CHEP amplitude with intraepidermal nerve fiber density. Clin Neurophysiol 2008;119:653–661.
23.
Atherton DDFacer PRoberts KMMisra VPChizh BABountra CAnand P. Use of the novel contact heat evoked potential stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre countsBMC Neurol2007721. 23. Atherton DD, Facer P, Roberts KM, Misra VP, Chizh BA, Bountra C, Anand P: Use of the novel contact heat evoked potential stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts. BMC Neurol 2007;7:21.
24.
Casanova-Molla JGrau-Junyent JMMorales MValls-Solé J. On the relationship between nociceptive evoked potentials and intraepidermal nerve fiber density in painful sensory polyneuropathiesPain2011152410-418. 24. Casanova-Molla J, Grau-Junyent JM, Morales M, Valls-Solé J: On the relationship between nociceptive evoked potentials and intraepidermal nerve fiber density in painful sensory polyneuropathies. Pain 2011;152:410–418.
25.
Chao CCTseng MTLin YJYang WSHsieh SCLin YHChiu MJChang YCHsieh ST. Pathophysiology of neuropathic pain in type 2 diabetes: skin denervation and contact heat-evoked potentialsDiabetes Care2010332654-2659. 25. Chao CC, Tseng MT, Lin YJ, Yang WS, Hsieh SC, Lin YH, Chiu MJ, Chang YC, Hsieh ST: Pathophysiology of neuropathic pain in type 2 diabetes: skin denervation and contact heat-evoked potentials. Diabetes Care 2010;33:2654–2659.
26.
Wong MCChung JW. Feasibility of contact heat evoked potentials for detection of diabetic neuropathyMuscle Nerve201144902-906. 26. Wong MC, Chung JW: Feasibility of contact heat evoked potentials for detection of diabetic neuropathy. Muscle Nerve 2011;44:902–906.
27.
Tesfaye SBoulton AJDyck PJFreeman RHorowitz MKempler PLauria GMalik RASpallone VVinik ABernardi LValensi PToronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatmentsDiabetes Care2010332285-2293. 27. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P; Toronto Diabetic Neuropathy Expert Group: Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285–2293.
28.
Dyck PJ. Detection, characterization and staging of polyneuropathy: assessed in diabetesMuscle Nerve19881121-32. 28. Dyck PJ: Detection, characterization and staging of polyneuropathy: assessed in diabetes. Muscle Nerve 1988;11:21–32.
29.
Casellini CBarlow PRice ACasey MSimmons KPittenger GBastyr EJ 3rdWolka AMVinik AI. Effect of ruboxistaurin (RBX) on quantitative measures of diabetic peripheral neuropathy (DPN) [abstract 791-P]Presented at the American Diabetes Association 66th Annual Scientific SessionsJune9–122006Washington, DC. 29. Casellini C, Barlow P, Rice A, Casey M, Simmons K, Pittenger G, Bastyr EJ 3rd, Wolka AM, Vinik AI: Effect of ruboxistaurin (RBX) on quantitative measures of diabetic peripheral neuropathy (DPN) [abstract 791-P]. Presented at the American Diabetes Association 66th Annual Scientific Sessions, June 9–12, 2006, Washington, DC.
30.
Pittenger GSimmons KAnandacoomaraswamy DRice ABarlow PVinik A. Topiramate improves intraepidermal nerve fiber morphology and quantitative neuropathy measures in diabetic neuropathy patients [abstract]J Peripher Nerve Syst200510Suppl 173. 30. Pittenger G, Simmons K, Anandacoomaraswamy D, Rice A, Barlow P, Vinik A: Topiramate improves intraepidermal nerve fiber morphology and quantitative neuropathy measures in diabetic neuropathy patients [abstract]. J Peripher Nerve Syst 2005;10(Suppl 1):73.
31.
Vinik AIErbas TPark TS. Methods for evaluation of peripheral neurovascular dysfunctionDiabetes Technol Ther2001329-50. 31. Vinik AI, Erbas T, Park TS: Methods for evaluation of peripheral neurovascular dysfunction. Diabetes Technol Ther 2001;3:29–50.
32.
Witzke KAVinik AIGrant LMParson HKPittenger GLBurcus N. Loss of RAGE defense: a cause of Charcot neuroarthropathy?Diabetes Care2011341617-1621. 32. Witzke KA, Vinik AI, Grant LM, Parson HK, Pittenger GL, Burcus N: Loss of RAGE defense: a cause of Charcot neuroarthropathy? Diabetes Care 2011;34:1617–1621.
33.
Casellini CMBarlow PMRice ALCasey MSimmons KPittenger GBastyr EJ 3rdWolka AMVinik AI. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-β inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathyDiabetes Care200730896-902. 33. Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G, Bastyr EJ 3rd, Wolka AM, Vinik AI: A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-β inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care 2007;30:896–902.
34.
Vinik AIZiegler D. Diabetic cardiovascular autonomic neuropathyCirculation2007115387-397. 34. Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation 2007;115:387–397.
35.
Lieb DCParson HKMamikunian GVinik AI. Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammationExp Diabetes Res20122012878760. 35. Lieb DC, Parson HK, Mamikunian G, Vinik AI: Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation. Exp Diabetes Res 2012;2012:878760.
36.
Rosier EIadarola MCoghill R. Reproducibility of pain measurement and pain perceptionPain200298205-216. 36. Rosier E, Iadarola M, Coghill R: Reproducibility of pain measurement and pain perception. Pain 2002;98:205–216.
37.
DeLong ERDeLong DMClarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approachBiometrics198844837-845. 37. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837–845.
38.
Vinik AMaser RZiegler D. Autonomic imbalance: prophet of doom or scope for hope?Diabet Med201128643-651. 38. Vinik A, Maser R, Ziegler D: Autonomic imbalance: prophet of doom or scope for hope? Diabet Med 2011;28:643–651.
39.
Howard MACoen SJBuchanan TJSmart TSGregory SLWilliams SCHuggins JPHanna M. Test-retest reproducibility of cerebral and subjective responses to painful and non-painful contact-heat evoked potential stimulation (CHEPS) [abstract]Eur J Pain200610Suppl S1S82. 39. Howard MA, Coen SJ, Buchanan TJ, Smart TS, Gregory SL, Williams SC, Huggins JP, Hanna M: Test-retest reproducibility of cerebral and subjective responses to painful and non-painful contact-heat evoked potential stimulation (CHEPS) [abstract]. Eur J Pain 2006;10(Suppl S1):S82.
40.
Chen IAHung SWChen YHLim SNTsai YTHsiao CLHsieh HYWu T. Contact heat evoked potentials in normal subjectsActa Neurol Taiwan200615184-191. 40. Chen IA, Hung SW, Chen YH, Lim SN, Tsai YT, Hsiao CL, Hsieh HY, Wu T: Contact heat evoked potentials in normal subjects. Acta Neurol Taiwan 2006;15:184–191.
41.
Wydenkeller SWirz RHalder P. Spinothalamic tract conduction velocity estimated using contact heat evoked potentials: what needs to be consideredClin Neurophysiol2008119812-821. 41. Wydenkeller S, Wirz R, Halder P: Spinothalamic tract conduction velocity estimated using contact heat evoked potentials: what needs to be considered. Clin Neurophysiol 2008;119:812–821.
42.
Wydenkeller SMaurizio SDietz VHalder P. Neuropathic pain in spinal cord injury: significance of clinical and electrophysiological measuresEur J Neurosci20093091-99. 42. Wydenkeller S, Maurizio S, Dietz V, Halder P: Neuropathic pain in spinal cord injury: significance of clinical and electrophysiological measures. Eur J Neurosci 2009;30:91–99.
43.
Selvarajah DWilkinson IDEmery CJHarris NDShaw PJWitte DRGriffiths PDTesfaye S. Early involvement of the spinal cord in diabetic peripheral neuropathyDiabetes Care2006292664-2669. 43. Selvarajah D, Wilkinson ID, Emery CJ, Harris ND, Shaw PJ, Witte DR, Griffiths PD, Tesfaye S: Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care 2006;29:2664–2669.

Information & Authors

Information

Published In

cover image Diabetes Technology & Therapeutics
Diabetes Technology & Therapeutics
Volume 15Issue Number 2February 2013
Pages: 150 - 157
PubMed: 23298343

History

Published in print: February 2013
Published online: 29 January 2013
Published ahead of print: 8 January 2013

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Henri K. Parson
Strelitz Diabetes Center for Endocrine and Metabolic Disorders; and Division of Endocrinology and Metabolism, Department of Medicine, Eastern Virginia Medical School, Norfolk, Virginia.
Van T. Nguyen
Strelitz Diabetes Center for Endocrine and Metabolic Disorders; and Division of Endocrinology and Metabolism, Department of Medicine, Eastern Virginia Medical School, Norfolk, Virginia.
Michael-Angelo Orciga
Strelitz Diabetes Center for Endocrine and Metabolic Disorders; and Division of Endocrinology and Metabolism, Department of Medicine, Eastern Virginia Medical School, Norfolk, Virginia.
Amanda L. Boyd
Strelitz Diabetes Center for Endocrine and Metabolic Disorders; and Division of Endocrinology and Metabolism, Department of Medicine, Eastern Virginia Medical School, Norfolk, Virginia.
Carolina M. Casellini
Strelitz Diabetes Center for Endocrine and Metabolic Disorders; and Division of Endocrinology and Metabolism, Department of Medicine, Eastern Virginia Medical School, Norfolk, Virginia.
Aaron I. Vinik
Strelitz Diabetes Center for Endocrine and Metabolic Disorders; and Division of Endocrinology and Metabolism, Department of Medicine, Eastern Virginia Medical School, Norfolk, Virginia.

Notes

Address correspondence to:Aaron I. Vinik, MDStrelitz Diabetes Center for Endocrine and Metabolic Disorders855 West Brambleton AvenueNorfolk, VA 23510E-mail: [email protected]

Author Disclosure Statement

The authors declare no competing financial interests.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top